Masimo and Philips Renew Strategic Partnership to Advance Patient Monitoring

Masimo and Philips have renewed a multi-year strategic collaboration to accelerate integration of Masimo’s patient monitoring technologies into Philips’ multi-parameter monitors and expand innovation in areas such as artificial intelligence. The agreement follows Philips’ July renewal of a similar partnership with Masimo competitor Medtronic, which had raised questions about Masimo’s relationship with Philips during its Q2 2025 earnings call.

Under the renewed deal, integration of Masimo’s SET pulse oximetry—used to track oxygen saturation and pulse rate—will continue through 2026 and beyond. Philips will also expand adoption of Masimo technologies that measure continuous hemoglobin and brain function across more devices and care settings.

The partnership includes integrating Masimo’s Radius PPG wearable sensor with Philips monitors and next-generation wearable devices. Philips emphasized that the collaboration aligns with its strategy to support vendor-neutral interoperability across healthcare systems, enabling more flexible and connected patient care solutions.

15-09-2025